A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Inclusion Criteria: * Adults \>18 years of age * Type 2 diabetes mellitus * Hospitalization for ACS event and randomization between hospital discharge and 8 weeks after the ACS index event (day of hospitalization) Exclusion Criteria: * Estimated glomerular filtration rate \<45 mL/min/1.73m2 * Concomitant treatment with a thiazolidinedione and/or fibrate * Triglycerides \>400 mg/dL * Anaemia * Symptomatic congestive heart failure classified as New York Heart Association (NYHA) class II-IV (France and Germany: Symptomatic congestive heart failure classified as NYHA class I-IV)